- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02241733
Sustainability of Pulmonary Rehab Gains
Sustainability of Rehabilitation Gains in COPD
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Rationale: Development of dynamic hyperinflation is a primary limiting factor of exercise tolerance in chronic obstructive pulmonary disease (COPD). To lessen the development of dynamic hyperinflation, and to improve exercise tolerance in COPD patients, the investigators have developed a breathing-retraining technique to be used during pulmonary rehabilitation. This breathing-retraining technique is designed to decrease respiratory rate and prolong exhalation. The investigators demonstrated that, in the short-term, hyperinflation and exercise duration improved more with breathing-retraining plus exercise-training than with exercise-training alone. Because a crucial aspect of pulmonary rehabilitation is the maintenance its short-term benefits over the long-term, the investigators now propose to test whether short-term benefits of breathing-retraining plus exercise followed by an adherence-intervention program are sustainable over the long-term Primary Hypothesis: (H1) In COPD patients, improvements in exercise duration on a constant- load treadmill test will be greater after 12 weeks of breathing-retraining plus exercise-training followed by a 42-week adherence-intervention program (1 yr. total) than after 12 weeks of exercise-training alone followed by a 42-week adherence-intervention program (1 yr. total). Secondary Hypotheses: One year after randomization, exercise-induced dynamic hyperinflation will be less during a constant-load treadmill test (H2), 6-minute walking distance will be longer (H3), and mastery over breathing will be greater (H4) in the breathing-retraining plus exercise-training group than in the exercise-alone group. Lastly (exploratory objective), the investigators will assess the effect of the patient's physiologic, psychologic and clinical phenotype on short- term and long-term responsiveness to pulmonary rehabilitation.
Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are expected to qualify for randomization into the breathing-retraining plus exercise-training group or the exercise-training alone group. Patients will receive 12-weeks of supervised training according to group assignment (three times weekly) followed by an adherence-intervention program (weekly phone motivational interviews, home-exercise program, and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks, and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography. Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1) the investigators will compare changes in exercise duration (constant work-rate treadmill test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary analysis will be based on intention-to-treat principles. Multiple imputation will be used for study subjects missing the 12-month measurement. This imputation model will be based on baseline characteristics of study participants. Several secondary analyses of the primary outcome measure will be performed (H2-H4). Linear regression will be used to determine whether the observed treatment benefits persist after adjustment for baseline covariates and measures of adherence to treatment. Since several measurements will be taken on each patient, mixed-models analysis will be used to compare the changes on the constant-load treadmill test over time between the two groups.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Illinois
-
Hines, Illinois, Stati Uniti, 60141-5000
- Edward Hines Jr. VA Hospital, Hines, IL
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- >/= 40 yrs
- FEV1 </= 70% predicted
- FEV1/FVC <70% predicted
- RV/TLC >/=120%
- SpO2 >/= 90% at peak exercise (with or without exercise)
- inspiratory capacity decline >.15L from rest to peak exercise
Exclusion Criteria:
- respiratory infection/exacerbation within the previous 4 weeks
- exercise limiting heart disease
- primary asthma
- congestive heart failure
- exercise limiting peripheral arterial disease
- stops exercise due to arthritic pain in the knee or hips
- inability to walk on the treadmill
- pregnancy
- methadone use
- any unforeseen illness or disability that would preclude exercise testing or training
- participation in a formal exercise program within the previous 12 weeks
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione fattoriale
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: exercise
Patients will exercise for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program .
They will also participate in an adherence program.
|
|
Sperimentale: exercise plus breathing retraining
Patients will exercise plus breathing retraining for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program with breathing retraining.
They will also participate in an adherence program.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Duration of Exercise Time on a Constant Work-rate Treadmill Test
Lasso di tempo: 52 week test
|
Patients walk on a treadmill set at a constant workrate.
The difference in the time walked on the treadmill from baseline to study completion is the primary outcome measure.
|
52 week test
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Inspiratory Capacity
Lasso di tempo: 52 week test
|
Inspiratory capacity is measured at a set time during the constant workrate treadmill test.
The difference between the inspiratory capacity measured at baseline and 52 weeks is a secondary outcome.
Inspiratory capacity measured during exercise is a measure of dynamic hyperinflation.
|
52 week test
|
|
6 Minute Walk Distance
Lasso di tempo: 52 weeks
|
Six-minute walk distance will be measured at 52 weeks.
The difference in distance walked in meters between baseline and 52 weeks is the secondary outcome measure.
The 6 minute walk is conducted using the guidelines issued by the American Thoracic Society.
|
52 weeks
|
|
Mastery Over Breathing
Lasso di tempo: 52 weeks
|
Mastery over breathing is measured using the Chronic Respiratory Disease Questionnaire.
Specifically the subscale 'mastery" is the investigators' secondary outcome.
The difference in scores from baseline to 52 weeks is the investigators' outcome measure.
The Chronic Respiratory Disease Questionnaire is a valid and reliable questionnaire.
1=minimum score, 7=maximum with the higher score indicating greater mastery.
A higher score indicates better health.
A change of 0.5 indicates a small change, 1.0 indicates a moderate change and greater or equal to a change of 1.5 indicates a large change.
|
52 weeks
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Eileen G. Collins, PhD RN, Edward Hines Jr. VA Hospital, Hines, IL
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- O1325-R
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su BPCO
-
Fraunhofer-Institute of Toxicology and Experimental...Institute for Pharmacology and Toxicology, RWTH AachenCompletatoVolontari sani | COPD GOLD da I a IV | Asma GINA da 1 a 4Germania
Prove cliniche su Exercise only
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR); AbbottReclutamentoFibrillazione atriale | Ablazione transcatetere con radiofrequenza | Ablazione transcatetereCanada
-
Gadjah Mada UniversityReclutamentoCancro ai polmoni (diagnosi) | Biopsia, ago sottile/metodiIndonesia
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... e altri collaboratoriCompletato
-
The University of Texas Health Science Center,...Completato
-
BetterMe LimitedNon ancora reclutamento
-
Wayne State UniversityNon ancora reclutamentoDisturbo da stress post-traumatico | Disturbo post traumatico da stressStati Uniti
-
AtaCor Medical, Inc.CompletatoDifetto di conduzioneNuova Zelanda, Paraguay
-
Hungkuang UniversitySchweitzer Biotech CompanyAttivo, non reclutanteAlopecia | Condizione dei capelli | La perdita di capelli | Diradamento dei capelli | Produzione di sebo | Salute del cuoio capelluto | Salute dei capelliTaiwan
-
New Mexico Cancer Research AllianceNational Cancer Institute (NCI); University of New Mexico Cancer CenterNon ancora reclutamentoIperplasia endometriale | Adenocarcinoma endometrioide endometrialeStati Uniti